The Gut-liver Axis in Sepsis: Interaction Mechanisms and Therapeutic Potential

Overview

Journal Crit Care

Specialty Critical Care

Date 2022 Jul 13

PMID 35831877

Authors

Xue Zhang

Hong Liu

Kenji Hashimoto

Shiying Yuan

Jiancheng Zhang

Affiliations

Soon will be listed here.

Abstract

Sepsis is a potentially fatal condition caused by dysregulation of the body's immune response to an infection. Sepsis-induced liver injury is considered a strong independent prognosticator of death in the critical care unit, and there is anatomic and accumulating epidemiologic evidence that demonstrates intimate cross talk between the gut and the liver. Intestinal barrier disruption and gut microbiota dysbiosis during sepsis result in translocation of intestinal pathogen-associated molecular patterns and damage-associated molecular patterns into the liver and systemic circulation. The liver is essential for regulating immune defense during systemic infections via mechanisms such as bacterial clearance, lipopolysaccharide detoxification, cytokine and acute-phase protein release, and inflammation metabolic regulation. When an inappropriate immune response or overwhelming inflammation occurs in the liver, the impaired capacity for pathogen clearance and hepatic metabolic disturbance can result in further impairment of the intestinal barrier and increased disruption of the composition and diversity of the gut microbiota. Therefore, interaction between the gut and liver is a potential therapeutic target. This review outlines the intimate gut-liver cross talk (gut-liver axis) in sepsis.

Citing Articles

Interleukins-27 Aggravates Liver Injury by Impairing the Antimicrobial Response of Macrophages via the Promotion of Mitochondrial Dysfunction in the Context of Sepsis.

You Y, Li Y, Ye L, Xu F, Fan J Mediators Inflamm. 2025; 2025:6608718.

PMID: 40046257 PMC: 11882325. DOI: 10.1155/mi/6608718.

Metasilicate-based alkaline mineral water improves the growth performance of weaned piglets by maintaining gut-liver axis homeostasis through microbiota-mediated secondary bile acid pathway.

Chen J, Malhi K, Li X, Xu X, Kang J, Zhao B Anim Nutr. 2025; 20:95-109.

PMID: 39949730 PMC: 11821399. DOI: 10.1016/j.aninu.2024.09.003.

Regulatory role of S1P and its receptors in sepsis-induced liver injury.

Wang B, Wu X, Cheng J, Ye J, Zhu H, Liu X Front Immunol. 2025; 16:1489015.

PMID: 39935473 PMC: 11811114. DOI: 10.3389/fimmu.2025.1489015.

IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury.

Zeng L, Wang Y, Huang Y, Yang W, Zhou P, Wan Y Cell Commun Signal. 2025; 23(1):63.

PMID: 39910615 PMC: 11796036. DOI: 10.1186/s12964-025-02075-5.

Shielding the Gut: Ghrelin and Ferrostatin-1's Protective Role Against Sepsis-Induced Intestinal Ferroptosis.

Hou Q, Dou Z, Zhu L, Li B Biomedicines. 2025; 13(1.

PMID: 39857660 PMC: 11761253. DOI: 10.3390/biomedicines13010077.

References

Leventhal J, Schroppel B . Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int. 2012; 81(9):826-32. DOI: 10.1038/ki.2011.498. View

Oami T, Watanabe E, Hatano M, Teratake Y, Fujimura L, Sakamoto A . Blocking Liver Autophagy Accelerates Apoptosis and Mitochondrial Injury in Hepatocytes and Reduces Time to Mortality in a Murine Sepsis Model. Shock. 2017; 50(4):427-434. DOI: 10.1097/SHK.0000000000001040. View

Cotter P, Hill C, Ross R . Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005; 3(10):777-88. DOI: 10.1038/nrmicro1273. View

Peterson L, Artis D . Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014; 14(3):141-53. DOI: 10.1038/nri3608. View

Knoop K, McDonald K, McCrate S, McDole J, Newberry R . Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol. 2014; 8(1):198-210. PMC: 4268115. DOI: 10.1038/mi.2014.58. View

Wong C, Jenne C, Petri B, Chrobok N, Kubes P . Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol. 2013; 14(8):785-92. PMC: 4972575. DOI: 10.1038/ni.2631. View

Shetty S, Lalor P, Adams D . Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol. 2018; 15(9):555-567. PMC: 7096836. DOI: 10.1038/s41575-018-0020-y. View

Fonseca R, Shimizu Bassi G, Brito C, Rosa L, David B, Araujo A . Vagus nerve regulates the phagocytic and secretory activity of resident macrophages in the liver. Brain Behav Immun. 2019; 81:444-454. PMC: 7826199. DOI: 10.1016/j.bbi.2019.06.041. View

Berbee J, van der Hoogt C, Kleemann R, Schippers E, Kitchens R, van Dissel J . Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J. 2006; 20(12):2162-4. DOI: 10.1096/fj.05-5639fje. View

10.

Surewaard B, Thanabalasuriar A, Zeng Z, Tkaczyk C, Cohen T, Bardoel B . α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis. Cell Host Microbe. 2018; 24(2):271-284.e3. PMC: 6295203. DOI: 10.1016/j.chom.2018.06.017. View

11.

Gulubova M . Expression of cell adhesion molecules and their beta1 and beta2 integrin ligands in human liver peliosis. Pathol Res Pract. 2005; 201(7):503-11. DOI: 10.1016/j.prp.2005.05.006. View

12.

Szabo G, Dolganiuc A, Mandrekar P . Pattern recognition receptors: a contemporary view on liver diseases. Hepatology. 2006; 44(2):287-98. DOI: 10.1002/hep.21308. View

13.

Quinn R, Phelan V, Whiteson K, Garg N, Bailey B, Lim Y . Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome. ISME J. 2015; 10(6):1483-98. PMC: 5029181. DOI: 10.1038/ismej.2015.207. View

14.

Doe W . The intestinal immune system. Gut. 1989; 30(12):1679-85. PMC: 1434429. DOI: 10.1136/gut.30.12.1679. View

15.

McKenney E, Kendall M . Microbiota and pathogen 'pas de deux': setting up and breaking down barriers to intestinal infection. Pathog Dis. 2016; 74(5). PMC: 5985477. DOI: 10.1093/femspd/ftw051. View

16.

Cao Y, Wang Z, Wang Z, Jiang X, Lu W . Inhibition of miR-155 alleviates sepsis-induced inflammation and intestinal barrier dysfunction by inactivating NF-κB signaling. Int Immunopharmacol. 2020; 90:107218. DOI: 10.1016/j.intimp.2020.107218. View

17.

Xu F, Ma Y, Huang W, Gao J, Guo M, Li J . Typically inhibiting USP14 promotes autophagy in M1-like macrophages and alleviates CLP-induced sepsis. Cell Death Dis. 2020; 11(8):666. PMC: 7441392. DOI: 10.1038/s41419-020-02898-9. View

18.

Morowitz M, Di Caro V, Pang D, Cummings J, Firek B, Rogers M . Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis. Crit Care Med. 2017; 45(5):e516-e523. PMC: 5392159. DOI: 10.1097/CCM.0000000000002291. View

19.

Sterns R, Grieff M, Bernstein P . Treatment of hyperkalemia: something old, something new. Kidney Int. 2016; 89(3):546-54. DOI: 10.1016/j.kint.2015.11.018. View

20.

Mantovani A, Biswas S, Galdiero M, Sica A, Locati M . Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2012; 229(2):176-85. DOI: 10.1002/path.4133. View